Leukaemia UK Opens Final Project Grant Round Before 2027 Pause, Offering Up to £250,000 for Translational Blood Cancer Research
核心洞察
Leukaemia UK (搜索)'s 2026 Project Grants round, the final cycle before a planned pause in 2027, offers up to £250,000 (~USD $317,000) over three years for senior group leaders at UK institutions.
The scheme prioritizes novel, translational research into leukemia (搜索) and precursor conditions including MDS, MPN, and CHIP, with lymphoma and myeloma explicitly excluded from scope.
Funding covers salary and direct costs but not equipment or institutional overheads, with applications due by midday on 8 July 2026.
Leukaemia UK (搜索) has launched its 2026 Project Grants round, marking what the charity confirms will be the final cycle before the scheme is paused in 2027. The funding opportunity, open to senior group leaders at UK research institutions, offers up to £250,000 (approximately USD $317,000) over three years for novel, clearly defined research into leukemia (搜索) and related precursor conditions.
The scheme targets established clinician scientists and research scientists operating at group-leader level, with a firm emphasis on work that demonstrates a clear translational pathway. "It funds senior group leaders to pursue novel, clearly defined research into leukemia (搜索) and precursor conditions such as MDS, MPN, and CHIP, with a hard preference for work that has a clear line of sight to translation and patient benefit," the charity states in its call documentation.
Scope and Exclusions
Leukaemia UK (搜索) has drawn explicit boundaries around the research it will support. Lymphoma and myeloma are out of scope, as is any topping-up of existing projects. The grants cover salary and direct costs but do not extend to equipment purchases or institutional overheads, requiring applicants to secure those resources through other means.
The precursor conditions named — myelodysplastic syndromes (MDS) (搜索), myeloproliferative neoplasms (MPN) (搜索), and clonal hematopoiesis of indeterminate potential (CHIP) (搜索) — reflect a growing research interest in intercepting hematological malignancies before they progress to overt leukemia (搜索).
A Closing Window
The charity's decision to pause the Project Grants scheme after 2026 adds urgency to this cycle. "This is the last Project Grant round before Leukaemia UK (搜索) pauses the scheme in 2027," the organization cautions. "If your work needs a full project-scale award, this cycle is the window; do not defer a strong proposal to a round that will not exist next year."
Applications must be submitted by midday UK time on 8 July 2026, though the charity notes that internal institutional deadlines may fall earlier. Lead applicants must hold positions at UK research institutions and be established at the group-leader level.
The pause in 2027 raises questions about the future shape of Leukaemia UK (搜索)'s research funding strategy, though the charity has not disclosed whether the Project Grants scheme will be replaced, restructured, or permanently retired after this final round.